Profiling neuroprotective potential of trehalose in animal models of neurodegenerative diseases: a systematic review
Open Access
- 1 January 2023
- journal article
- review article
- Published by Medknow in Neural Regeneration Research
- Vol. 18 (6) , 1179-1185
Abstract
Ehalose on its underlying mechanisms in animal models of selected neurodegenerative disorders (tau pathology, synucleinopathy, polyglutamine tract, and motor neuron diseases). All animal studies on neurodegenerative diseases treated with trehalose published in Medline (accessed via EBSCOhost) and Scopus were considered. Of the 2259 studies screened, 29 met the eligibility criteria. According to the SYstematic Review Center for Laboratory Animal Experiment (SYRCLE) risk of bias tool, we reported 22 out of 29 studies with a high risk of bias. The present findings support the purported role of trehalose in autophagic flux and protein refolding. This review identified several other lesser-known pathways, including modifying amyloid precursor protein processing, inhibition of reactive gliosis, the integrity of the blood-brain barrier, activation of growth factors, upregulation of the downstream antioxidant signaling pathway, and protection against mitochondrial defects. The absence of adverse events and improvements in the outcome parameters were observed in some studies, which supports the transition to human clinical trials. It is possible to conclude that trehalose exerts its neuroprotective effects through both direct and indirect pathways. However, heterogeneous methodologies and outcome measures across the studies rendered it impossible to derive a definitive conclusion. Translational studies on trehalose would need to clarify three important questions: 1) bioavailability with oral administration, 2) optimal time window to confer neuroprotective benefits, and 3) optimal dosage to confer neuroprotection....Keywords
This publication has 81 references indexed in Scilit:
- Stimulation of autophagy is neuroprotective in a mouse model of human tauopathyAutophagy, 2012
- Preparation and evaluation of BBB-permeable trehalose derivatives as potential therapeutic agents for Huntington's diseaseMedChemComm, 2012
- Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathyBrain, 2012
- Polyglutamine Diseases: Where does Toxicity Come from? What is Toxicity? Where are We Going?Journal of Molecular Cell Biology, 2010
- Guidelines for preclinical animal research in ALS/MND: A consensus meetingAmyotrophic Lateral Sclerosis, 2010
- Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's diseaseJournal of Neuroscience Research, 2008
- Polyglutamine diseases: emerging concepts in pathogenesis and therapyHuman Molecular Genetics, 2007
- The roles of intracellular protein-degradation pathways in neurodegenerationNature, 2006
- Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington diseaseNature Medicine, 2004
- Glucose Transporters in the Transepithelial Transport of GlucoseJournal of Electron Microscopy, 1996